ArticlePoultry science2026
The Metabolic Reprogramming Mechanism of Astragalus Polysaccharide-Induced Immune Memory in HD11 Cells: Integrated Analysis Based on Glycolysis and the TLR2/mTOR Pathway.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate the immunomodulatory effects of APS on HD11 cells and its potential mechanisms. This study aimed to investigate the immunomodulatory effects of APS on HD11 cells and its underlying mechanisms. CCK-8 assays revealed that APS significantly promoted HD11 cell proliferation in a dose-dependent manner. Griess and lactate dehydrogenase (LDH) assays indicated that APS dose-dependently increased nitric oxide (NO) release and LDH activity, although these levels remained lower than those in the lipopolysaccharide (LPS) group. RT-qPCR analysis demonstrated that APS significantly upregulated the mRNA levels of IL-8, CXCL13, and iNOS, while downregulating CCR5. Additionally, APS enhanced the expression and activity of glycolysis-related enzymes while suppressing those of the pentose phosphate pathway. Western blot analysis revealed that APS upregulated the protein expression of TLR1, MyD88, p-mTOR, and HIF-1α, but downregulated TLR2, ERK, and NF-κB p65. Metabolic assays showed a dose-dependent increase in Acetyl-CoA concentration and a decrease in glutathione (GSH) content following APS treatment. Mechanistically, small interfering RNA (siRNA)-mediated knockdown of TLR2 and mTOR demonstrated that APS regulates the mTOR signaling pathway via TLR2. Furthermore, mTOR silencing significantly attenuated the APS-induced expression of immune-related factors, accumulation of Acetyl-CoA, and reduction of GSH, confirming the central role of the mTOR signaling pathway in APS-mediated immunomodulation. In conclusion, APS enhances the immune response of HD11 cells by regulating TLRs signaling pathways, promoting glycolytic metabolism, and activating the mTOR pathway, providing a theoretical basis for the application of APS in poultry immunomodulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.